Related Experiment Video

Updated: Feb 17, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.6K

CDK4 expression in chordoma: A potential therapeutic target

Tang Liu1,2, Jacson K Shen1, Edwin Choy1

  • 1UCLA Orthopaedic Surgery, Sarcoma Biology Laboratory, 615 Charles E Young Dr. South, Biomedical Sciences Research Building, Room 410, Los Angeles, CA 90095.

Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|December 2, 2017
PubMed

Insights

Targeting cyclin-dependent kinase 4 (CDK4) shows promise for chordoma treatment. High CDK4 expression in chordoma tissues correlates with metastasis and recurrence, and inhibiting it slows tumor growth.

Area of Science:

  • Orthopaedic Oncology
  • Cancer Biology
  • Molecular Therapeutics

Background:

  • Chordomas are rare bone tumors lacking standard chemotherapy.
  • Current treatments rely on surgery and radiotherapy.
  • Understanding molecular targets is crucial for novel therapies.

Purpose of the Study:

  • To investigate cyclin-dependent kinase 4 (CDK4) expression in chordoma.
  • To explore the functional role of CDK4 in chordoma cell growth and proliferation.
  • To evaluate the therapeutic potential of targeting CDK4 in chordoma.

Main Methods:

  • CDK4 expression analysis in chordoma cell lines and patient tissues.
  • Functional studies on CDK4's role in cell growth and proliferation.
  • In vitro treatment with CDK4 inhibitor palbociclib.

Main Results:

  • CDK4 was highly expressed in chordoma cell lines and 97.7% of tissues.
  • Elevated CDK4 expression correlated with chordoma metastasis and recurrence.
  • Palbociclib treatment significantly inhibited chordoma cell growth and proliferation.

Conclusions:

  • CDK4 is a highly expressed protein in chordoma.
  • Targeting CDK4 represents a potential novel therapeutic strategy for chordoma.
  • CDK4 inhibition may offer a new treatment avenue for chordoma patients.
Keywords:
CDK4CDK6chordomap16INK4Apalbociclib

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.8K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K